289 related articles for article (PubMed ID: 17458051)
1. Asthma: fatal exacerbations with long-acting beta2 agonist therapy without concomitant steroid therapy.
Prescrire Int; 2007 Apr; 16(88):69-70. PubMed ID: 17458051
[TBL] [Abstract][Full Text] [Related]
2. Safety of long-acting beta2-agonists in the treatment of asthma.
Cazzola M; Matera MG
Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
[TBL] [Abstract][Full Text] [Related]
3. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
4. [Caution recommended in prescribing long-acting beta2-adrenergic agonists to patients with asthma].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):889-91. PubMed ID: 16686087
[TBL] [Abstract][Full Text] [Related]
5. Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials.
Sears MR; Ottosson A; Radner F; Suissa S
Eur Respir J; 2009 Jan; 33(1):21-32. PubMed ID: 18768573
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy.
Weatherall M; Wijesinghe M; Perrin K; Harwood M; Beasley R
Thorax; 2010 Jan; 65(1):39-43. PubMed ID: 20029037
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol: a long-acting beta 2-agonist.
D'Alonzo GE; Tolep K
J Am Osteopath Assoc; 1998 Apr; 98(4):216-8, 221-31. PubMed ID: 9594486
[TBL] [Abstract][Full Text] [Related]
8. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
Prenner BM
Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.
Salpeter SR; Buckley NS; Ormiston TM; Salpeter EE
Ann Intern Med; 2006 Jun; 144(12):904-12. PubMed ID: 16754916
[TBL] [Abstract][Full Text] [Related]
10. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
Campbell LM
Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
[TBL] [Abstract][Full Text] [Related]
11. Salmeterol and formoterol: asthma aggravation. Use should be restricted.
Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19743580
[No Abstract] [Full Text] [Related]
12. Safety of formoterol in adults and children with asthma: a meta-analysis.
Kemp J; Armstrong L; Wan Y; Alagappan VK; Ohlssen D; Pascoe S
Ann Allergy Asthma Immunol; 2011 Jul; 107(1):71-8. PubMed ID: 21704888
[TBL] [Abstract][Full Text] [Related]
13. Current trends in asthma therapy.
Sztanke K; Pasternak K
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):290-3. PubMed ID: 15323207
[TBL] [Abstract][Full Text] [Related]
14. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
Rabe KF
Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
[TBL] [Abstract][Full Text] [Related]
15. Long-acting beta-agonists role in asthma management.
Donohue JF; Fromer L
J Fam Pract; 2006 Apr; Suppl():1-6. PubMed ID: 16715643
[TBL] [Abstract][Full Text] [Related]
16. The long and short of beta2-agonists.
Lötvall J
Pulm Pharmacol Ther; 2002; 15(6):497-501. PubMed ID: 12493336
[TBL] [Abstract][Full Text] [Related]
17. What is new with the beta2-agonists: issues in the management of asthma.
Kelly HW
Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
[TBL] [Abstract][Full Text] [Related]
18. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
20. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ; Lasserson TJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
